Skip to main content

UBS Group AG

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in OTLK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$242,021
+$214,610 QoQ
Shares Held
152,215
+14.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 68 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OTLK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. OTLK ranks #330 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $242,021 152,215
2026-03-31 $27,411 133,069
2025-12-31 $331,071 209,540
2025-09-30 $50,999 48,114
2025-06-30 $88,197 55,124
2025-03-31 $115,414 94,603
2024-12-31 $541,757 286,644
2024-09-30 $38,213 7,156
2024-06-30 $17,785 2,410
2024-03-31 $111,316 9,323
2023-12-31 $49,570 125,813
2023-06-30 $8,760 5,035
2023-03-31 $9,936 9,116
2022-12-31 $19,635 18,181
2022-06-30 $1,466 1,438
2022-03-31 $4,878 2,741
2021-12-31 $43,368 31,889
2021-06-30 $12,629 5,072
2021-03-31 $15,412 6,850
2020-12-31 $11,700 9,000
2020-09-30 $5,389 7,485
2020-06-30 $11,610 9,000
2020-03-31 $112 187